Industry and Business Archives - Oncology Central Oncology Central

i
i

19 Dec 2019 Opinion
The best of 2019: an A–Z of cancer research and care
5 Dec 2019 Journal Articles
The economic burden of illness associated with localized prostate cancer in the United States
4 Dec 2019 Lung
US FDA approves atezolizumab plus chemotherapy for metastatic NSCLC
25 Nov 2019 Head and neck
Pembrolizumab approved as standard first-line therapy for head and neck cancer
28 Oct 2019 Hematologic
Gilteritinib approved in the EU for relapsed or refractory AML patients with a FLT3 mutation
21 Oct 2019 News
International alliance, driven by Cancer Research UK, targets the detection of cancer at its earliest stage
8 Aug 2019 Lung
Pembrolizumab receives the green light from NICE for NSCLC subtype
26 Jul 2019 Gynecologic
Olaparib made available on the NHS for BRCA-positive ovarian cancer patients
17 Jul 2019 News
Zejula® significantly improves progression-free survival in ovarian cancer patients
10 Jul 2019 Videos
Enhancing the efficacy of clinical trials with Jeffery Edenfield
18 Jun 2019 News
Study investigates why cancer drug prices are rising
23 May 2019 Opinion
ASCO 2019: what should you look out for?